2024 Tech4Eva - Femtech acceleration program - Call for Application

Thumbnail

Event details

Date 15.03.2024
Hour 16:0017:00
Category Deadline
Event Language English
A Joint program between EPFL Innovation Park and Groupe Mutuel

Do you have an innovative and disruptive FemTech solution and are you looking to accelerate your progress and gain visibility?
Then join the growing FemTech community of Tech4Eva and apply to this 6-month game changing accelerator starting in April 2024!

For this 4th cohort, they are looking for 10-15 innovative solutions in one or more of these areas: Pregnancy & post-partum – Mental health & wellbeing – Period health – Fertility & infertility – Endometriosis – Sexual & pelvic health – Oncology – Menopause care – Prevention & treatment – Bone & Brain Health – Immune & Heart Diseases – and with a special interest by corporate partners for solutions in Nutrition/Digestive/Hormonal Health…

*Tech4Eva welcomes global solutions of all areas and stages to apply. Preference will be given to start-ups with scientific evidence, having or ideally building a clinical or animal model, or in vitro for the mechanism of action, ideally IP protected or in submission, or having proof of concept / prototype / users / data / early adopters. Looking for Founders who are committed to participate in the program activities, open to discussions or suggestions of assigned mentors, willing to share his/her network to benefit others and determined to make progress. More info on the program: www.tech4eva.ch

ABOUT THIS APPLICATION
The program is equity free, virtual or hybrid and global. We accept early and growth stage applications in all sectors listed. Application deadline is March 15, 2024. Apply here: https://bit.ly/48nPuJZ

Links

Practical information

  • Informed public
  • Registration required

Organizer

  • Tech4Eva | Fondation EPFL Innovation Park 

Contact

Tags

pregnancy healthcare femtech prevention health_and_wellness menstrual_health wellness_events menopause_womens_health

Event broadcasted in

Share